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Stem cell behaviors are regulated by multiple
microenvironmental cues. As an external signal,
mechanical stiffness of the extracellular matrix is capable
of governing stem cell fate determination, but how this
biophysical cue is translated into intracellular signaling
remains elusive. Here, we elucidate mechanisms by
which stem cells respond to microenvironmental
stiffness through the dynamics of the cytoskeletal
network, leading to changes in gene expression via
biophysical transduction signaling pathways in
two-dimensional culture. Furthermore, a putative
rapid shift from original mechanosensing to de novo
cell-derived matrix sensing in more physiologically
relevant three-dimensional culture is pointed out. A
comprehensive understanding of stem cell responses
to this stimulus is essential for designing biomaterials
that mimic the physiological environment and
advancing stem cell-based clinical applications for
tissue engineering.environments, which are more physiologically relevant.Introduction
Stem cells hold enormous potential for treating a broad
spectrum of human diseases due to their multipotency
[1-3]. Besides biochemical signals, stem cell maintenance
and differentiation are regulated by biophysical aspects
of the microenvironment, including mechanical loading,
substrate material property and cell shape [4,5]. With
the development of biomimetic substrates, new data
continue to reveal more and more inspiring details of
extracellular matrix (ECM) stiffness, which profoundly
impacts on stem cell self-renewal and commitment
[6-8]. ECM stiffness is usually represented by the elastic
modulus or Young’s modulus. Generally, ECM stiffness,
which matches the stiffness of native tissue, guides stem* Correspondence: lilisha@jlu.edu.cn; ylli@jlu.edu.cn
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unless otherwise stated.cell differentiation down corresponding tissue lineages.
For instance, substrates approximating to the elastic
moduli of brain (0.1 to 1 kPa), pancreas (1.2 kPa), cartil-
age (3 kPa), muscle (8 to 17 kPa) and bone tissue (25 to
40 kPa) direct stem cells, especially mesenchymal stem
cells (MSCs), to commit to neurocytes, beta cells, chon-
drocytes, myoblasts and osteoblasts, respectively [6,9,10].
There is a growing interest in understanding how stem
cells feel and respond to specific stiffness; how the
mechanical cue is converted into intracellular signaling
cascades; and how gene expression changes and stem
cell fate are determined.
We summarize the mechanotransduction steps activated
by matrix stiffness in stem cell differentiation (Figure 1).
Based on recent experiments in two-dimensional models,
the mechanism of mechanotransduction of stem cells is
probably associated with the integrin-cytoskeletal-based
feedback loop between mechanical signals and biochemical
signals in the background of the signaling network to de-
termine their fates. Different mechanisms of matrix stiff-
ness mechanotransduction may exist in three-dimensionalIntegrin as the starting point for mechanosensing
The mechanical link between the ECM and the cytoskel-
eton are large protein assembly complexes known as
focal adhesions, which involve integrins as major adhe-
sion receptors [11]. Adapter proteins, including talin and
vinculin, connect the cytoskeleton with integrins. Integ-
rins are heterodimers comprising α and β subunits, each
with multiple types. The binding affinity and specificity
of these subunits for various ECM proteins are different,
and they also play different roles in regulating the re-
sponse of stem cells to mechanical properties of the
microenvironment. For instance, β3 integrin mediates
MSC myogenic differentiation induced by substrates
with medium stiffness [12], while α2 integrin modulates
osteogenesis of MSCs on stiff matrix [13]. As a vital cell
surface transmembrane receptor, integrin mediates focal
adhesion assembly, cytoskeletal organization, and ais an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Mechanism of mechanotransduction of stem cells activated by matrix stiffness. The initial tension caused by stress fiber contraction is
balanced by the microtubules resisting the resulting compression forces and the traction stress exerted on the extracellular matrix (ECM) across
the focal adhesions, which directly cause the resultant force determined by matrix stiffness, contributing to microtubule compression. Then, the
cell reads out the resultant forces from traction stress through the activation of integrin-mediated signal transduction pathways, which mediate
actin filament polymerization and therefore change stress fiber contractility. Also, the initial tension from stress fiber contraction and the opposing
compressive forces exerted by microtubules might also transmit into the nucleus and be resisted by lamin-A, which in turn promotes cell contractility
by activating the transcriptional pathway that regulates actin filament bundling. Through cytoskeleton-based feedback loops, a cell changes its
maximal mechanosensitivity close to the microtubule compression determined by matrix stiffness. Some transcriptional pathway modulates lamin-A
expression, and feedback by lamin-A indirectly regulates transcriptional pathways, which crosstalk with integrin-mediated signaling and ultimately
direct stem cell differentiation.
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through its activation during mechanotransduction [14].
Importantly, integrin transmits signals bidirectionally;
that is, integrin not only transmits outside-in signals
from the extracellular environment, but also passes
intracellular stimuli to the outside of the cells [15].
The intracellular stimuli induce talin and kindlin to bind
to the cytoplasmic domains of integrin β subunits, which
activates the binding of integrins and ligands [16].
A growing number of studies suggest that mechanical
stiffness modulates the self-renewal and differentiation
of stem cells through integrin-mediated transduction
pathways [13,17].
A host of intracellular signaling proteins are tightly
associated with focal adhesions, such as focal adhesion
kinase (FAK), a key component of mechanosensing.
Under mechanical stimulation, the conformation of
these signaling molecules may change, exposing phos-
phorylation sites and leading to activation of kinase
cascades, transport of intracellular signaling molecules
and changes in gene expression [18,19]. Among these
signaling molecules, integrins are essential for mechan-
ical signal perception, and are orientated at the start of
the process of mechanotransduction induced by matrix
stiffness [20].Integrin downstream signaling pathways
Integrin signaling interplays directly or indirectly with
other pathways during mechanotransduction, including
those involving RhoA, bone morphogenetic protein
(BMP)/Smad and FAK. β3 integrin activity and RhoA
signaling mediate the generation of cytoskeleton tension
[12]. MSCs on micropatterned ECM with medium stiff-
ness (10.2 kPa) preferentially recruit β3 integrin to
develop larger and elongated focal adhesion complexes,
which subsequently activate RhoA signaling [12]. It is
known that RhoA activity is regulated by a wealth of
GTP exchange factors or GTPase activating proteins
(GAPs), including p190RhoGAP. The activation of RhoA
leads to the stimulation of the contraction indicator my-
osin light chain kinase (MLCK), which cooperates with
acto-myosin and actin filaments to promote stress fiber
assembly to generate the appropriate cytoskeleton tension
[21]. Additionally, β1 integrin internalization inhibits the
BMP/Smad signaling pathway [17]. Soft substrates lead to
a substantial increase in the active form of β1 integrin and
a reduction in the cell surface distribution of β1 integrin
in MSCs by enhancing the detachment of integrin-ECM
protein complexes [17]. In turn, the detachment drives
activated integrin internalization through caveolae/raft-
dependent endocytosis. The enhanced uptake of β1
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of BMP receptor (BMPR) by promoting BMPR endo-
cytosis. This endocytosis prevents BMPR from binding
to ligands and thus inhibits the phosphorylation of
downstream Smad 1/5/8 [17]. Furthermore, the state
switches in α5β1 integrin link the cytoskeleton to FAK
pathways [20]. FAK is a fundamental signaling molecule
in the integrin-mediated signal transduction pathway
[22]. During the mechanosensing process, myosin II-
modulated cytoskeletal tension triggers the α5β1 integrin
to switch from a relaxed state to a tensioned state. The
switch in integrin state directly monitors the α5β1-
fibronectin bond strength via engaging the synergy site in
fibronectin, and links the cytoskeleton to FAK pathways
[20]. FAK signaling in turn promotes activation of integ-
rin, leading to enhanced cell adhesion on ECM [23].
Cytoskeletal-based feedback loops to reach
maximal mechanosensitivity
Various studies have demonstrated that substrate stiffness-
driven lineage specification of stem cells changes when
actomyosin contractility is blocked or increased by pharma-
cological cytoskeletal inhibitors in two-dimensional cultureTable 1 Effects of pharmacological cytoskeletal inhibitors on
Chemical Binding target Mechanism
Blebbistatin Myosin ATPase Inhibits actomyosin contractility by
blocking non-muscle myosin II ATPase
activity
ML-7 Myosin light chain
kinase
Inhibits actomyosin contractility by
blocking myosin light chain
phosphorylation
Y27632 ROCK Inhibits actomyosin contractility by
blocking the RhoA-ROCK pathway
Calyculin A Myosin light chain
phosphatase
Increases actomyosin contractility by
inhibiting the myosin light chain
phosphatase




Colchicine Tubulin Inhibits microtubule formation
ASC, adipose-derived stem cell; MSC, mesenchymal stem cell; ROCK, Rho associated[6,24-26] (Table 1). In other words, actomyosin contractility
is critical for cells to perceive the stiffness of the micro-
environment. Actomyosin contractility is modulated by
actomyosin or myosin through sliding actin filaments in a
polar fashion [27], and actomyosin filaments, known as
stress fibers, mediate signal transduction from the ECM
through integrins [28]. The response of the contraction rate
or the contractile traction force results specifically from
substrate stiffness and not cell tension or height. In an
atomic force microscopy experiment [29], the cellular con-
traction rate, which represents the change in contractile
traction force per unit time (dF/dt), rapidly increased while
the corresponding contraction velocity, which is the change
in cell height per unit time (dx/dt), decreased in response
to increases in matrix stiffness. Focal adhesions, which
represent dynamic actin-integrin linkage, provide es-
sential ways of mechanical transmission of stiffness
sensing through the contractility of stress fibers at the
early stage of differentiation. Vinculin, a component of
focal adhesion complexes, displays a more punctate
structure on stiff substrates, but blocking of integrin-ECM
binding by arginine-glycine-aspartate-serine (RGDS) leads




MSCs Two-dimensional: blocks neurogenesis at 0.1 to 1
kPa, myogenesis at 8 to 17 kPa, osteogenesis at 25
to 40 kPa [6]; suppresses chondrogenesis at 1 kPa
[25]; inhibits osteogenesis at 47.5 kPa [24]
Mammary
progenitor cells
Two-dimensional: abrogates myoepithelial cell
differentiation at 4 kPa [60]
MSCs Three-dimensional: no obvious effect on hypertrophic
differentiation at approximately 53.6 kPa [48]; no
obvious effect on osteogenesis at 0.2 to 59 kPa [46]
MSCs Two-dimensional: blocks neurogenesis at 0.1 to 1
kPa, myogenesis at 8 to 17 kPa, osteogenesis at 25
to 40 kPa [6]
MSCs Three-dimensional: no obvious effect on
osteogenesis at 0.2 to 59 kPa [46]
Mammary
progenitor cells
Two-dimensional: abrogates myoepithelial cell
differentiation at 4 kPa [60]
MSCs Three-dimensional: no obvious effect on
hypertrophic differentiation at ~53.6 kPa [48]; no
obvious effect on osteogenesis at 0.2 ~ 59 kPa [46]
Mammary
progenitor cells
Two-dimensional: increases luminal epithelial cell
differentiation at 0.1 kPa [60]
ASCs Two-dimensional: reduces the cellular area and
aspect ratio of cells at 20 and 40 kPa and increases
adipogenesis at 2 to 40 kPa, especially at 2 kPa [61]
MSCs Three-dimensional: increases osteogenesis at 0.2 to
59 kPa [46]
MSCs Three-dimensional: no obvious effect on
osteogenesis at 0.2 to 59 kPa [46]
kinase.
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generate forces against the ECM, causing morphological
change, migration and differentiation of the cell [30]. Fur-
thermore, vimentin intermediate filaments, which are
known to directly interact with actin, integrins, and their
associated focal adhesions, may also act as mechanosen-
sing elements as they become more punctate with increas-
ing stiffness; and as vinculins, this punctate structure
disappears when integrin-ECM binding is blocked [26].
Notably, a cell has a maximal sensitivity for a particu-
lar value of stiffness, which depends on the cytoskeletal
structure and the F-actin organization; a computational
model has shown that the substrate stiffness sensitivity
of a cell is a bell-shaped distribution over the physio-
logical stiffness range [31]. Based on analysis of the cell
tensegrity model, cells adapt to elastically tunable sub-
strates by translating their peak sensitivity of substrate
stiffness towards a value closer to the present substrate
stiffness by actin filament bundling [31]. If microtubule
compression forces determined by substrate stiffness are
outside the range of the sensitivity of the cells (that is,
the substrate is too stiff or too soft for the cells), the
cells start reinforcing or dismantling their stress fibers
by increasing or decreasing actin filament bundling [31].
Therefore, MSCs cultured on matrices of medium and
high stiffness present a large spreading size, well-aligned
stress fibers and enhanced focal adhesion assembly, all
of which contribute to a high tension state, and promote
myogenic and osteogenic differentiation. Conversely, dif-
fuse actin filament networks and small spreading area
associated with a relatively poorly defined actin cytoskel-
eton and focal adhesion assembly are found if MSCs are
grown on low stiffness matrices, leading to a neuronal
phenotype [6,24] (Figure 2A).
As indicated by accumulating evidence, we speculate
that the cytoskeletal-based feedback loop to reach max-
imal sensitivity to stiffness dominates cellular mechano-
transduction. According to a cell tensegrity model-based
study [31], at the beginning of mechanosensing, the ini-
tial tension caused by actomyosin-modulated contractil-
ity not only allows adherent cells to exert traction stress
on surrounding substrates, but also causes microtubules
inside cells to experience a resisting compression force
[31]. Once cells exert traction stress and adhere to the
substratum, a resultant force modulated by matrix stiff-
ness directly acts on the microtubules as another com-
pression force [31]. Simultaneously, the initial tension
caused by acto-myosin contraction and the opposing
compressive forces exerted by microtubules may also be
transmitted into the nucleus through the cytoskeletal
network. And these forces can be resisted by the
mechanosensitive intermediate filament protein lamin-A
on the basis that lamin-A levels in nuclei of stem cells
correlate positively with increasing ECM stiffness[32,33]. More importantly, lamin-A knockdown facili-
tates MSC differentiation towards low-stress, adipogenic
phenotypes on soft substrates, whereas lamin-A overex-
pression promotes osteogenic phenotypes with high
cytoskeletal stress or tension on stiff matrix [34]. In turn,
lamin-A is likely to bind nuclear actin and influences cell
contractility by regulating serum response factor (SRF)
pathways, which is known to promote the expression of
stress fiber-associated proteins [35,36]. Therefore, lamin-
A could also sense the microtubule compression force
and contribute to cytoskeletal organization through SRF
pathways. Additionally, the microtubule compression
force may be perceived and balanced by other proteins,
such as vinculin and vimentin, both of which have been
shown to have important roles in the mechanotransduc-
tion of mechanical stiffness [26].
Following initial focal adhesion complex formation,
the resultant forces from myosin-dependent traction
stress on the substratum may lead to the recruitment
and activation of mechanosensitive integrin [37]. Acti-
vated integrin stimulates Rho GTPase and the down-
stream target protein Rho associated kinase (ROCK) to
further activate MLCK. Subsequently, activated MLCK
in turn mediates actin filament polymerization and
actomyosin-driven contraction to generate proper cyto-
skeleton tension, which modulates the development and
maturation of focal adhesions [37,38]. Alternatively,
mechanosensitive ion channels on the cell membrane
may form a molecular complex with stress fibers and
focal adhesions, and convert substrate stiffness into elec-
trical and calcium signals followed by the phosphoryl-
ation of MLCK, causing the reorganization of the actin
cytoskeleton [39]. Altogether, all these matrix stiffness-
induced changes in actomyosin contractility, micro-
tubule compression force, lamin-A level, ion channels
and integrin-mediated RhoA-ROCK pathways could con-
tribute to integrin binding and cytoskeletal organization,
and ultimately change cell mechnosensitivity.
Nuclear lamin circuit
The mechanosensitive lamin-A gene circuit appears to
be an important modulator of diverse transcriptional
pathways, including those involving retinoic acid (RA),
sterol regulatory element-binding transcription factor 1
(SREBP1), SRF, and Yes-associated protein 1 (YAP1), fa-
cilitating matrix stiffness-driven differentiation of MSCs
[34]. Lamin-A can suppress MSC adipogenesis on soft
substrates by decreasing the nuclear level of the adipo-
genic transcription factor SREBP1 [34]. Furthermore,
RA inhibits osteogenesis on stiff substrate, whereas an
RA antagonist not only augments osteoblast differentiation
but increases lamin-A levels as well [34]. Thus, it is likely
that the RA pathway, which is downstream of matrix
stiffness, modulates lamin-A transcription. Meanwhile, RA
Figure 2 Stem cell response to matrix stiffness by integin, cytoskeleton and signal transduction crosstalk. (A) Integrin binding and cytoskeletal
organization of stem cells seeded on substrates with varying stiffness. Left: on soft matrix stem cells present small spreading area, poorly defined
actin cytoskeleton, low levels of lamin-A and detachment of focal adhesion complexes, associated with the uptake of integrins. Middle: on
topographical substrates with medium stiffness, cells develop enlongated focal adhesions, intermediate levels of lamin-A, and well-aligned stress
fibers with a spindle-shaped morphology. Right: stem cells cultured on rigid matrices display a large spreading size, prominent stress fibers and
enhanced focal adhesion assembly, as well as high levels of lamin-A. BMP, bone morphogenetic protein; BMPR, bone morphogenetic protein
receptor; RTK, receptor tyrosine kinase. (B) Crosstalk between signal transduction pathways induced by matrix stiffness to modulate stem cell
lineage specification. Left: blocking of BMP/Smad signaling by enhanced uptake of β1 integrin through caveolae/raft-dependent endocytosis on
soft matrix drives mesenchymal stem cell (MSC) neurogenic differentiation; lamin-A inhibits adipogenic differentiation by suppressing the , sterol
regulatory element-binding transcription factor 1 (SREBP1) transcriptional pathway; blocking of integrin-mediated extracellular signal-regulated
kinase (ERK)/mitogen-activated protein kinase (MAPK) signaling, which may activate AP-1 by stimulation of Jun N-terminal kinase (JNK), leads to
keratinocyte differentiation of epidermal stem cells. Middle: on topographical substrates with medium stiffness, MSCs employ β3 integrin-RhoA-
Rho associated kinase (ROCK)-myosin light chain kinase (MLCK) pathways to promote actin filament bundling and stress fiber contraction to
create appropriate cytoskeletal tension, which further influences myogenic gene expression; medium stiffness acts through β1 integrin, causing a
reduction of p190RhoGAP, which results in nuclear localization of GATA2 and TFII-1 in a RhoA-independent manner, ultimately leading to
endothelial differentiation of cardiac stem cells; nuclear localization of GATA2 inhibits Yes-associated protein 1 (YAP1) signaling that drives
osteogenesis on stiff matrices. Right: on stiff matrix the α2-integrin-ROCK-FAK-ERK1/2 axis is shown to increase RUNX2 activity, leading to
osteoblast differentiation of MSCs; Ras pathway regulates phosphorylation levels of Smad1/5/8, ERK1/2 and AKT during osteogenic differentiation; the
retinoic acid (RA) pathway enhances lamin-A transcription, but feedback by lamin-A indirectly modulates nuclear localization of RA receptor gamma
(RARG), which can be inhibited by RA and promotes RUNX2 activity on stiff substrates; lamin-A also co-regulates SRF and YAP1 to drive osteogenesis;
SRF signaling in turn affects stress fiber contractility; increased intracellular Ca2+ ion concentration on rigid matrix may contribute to cytoskeleton
tension through the activation of MLCK. Broken lines, unknown or putative signaling; solid lines, as in published. Arrows indicate activation, blocked
lines inhibition.
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gamma (RARG) may be indirectly regulated by feedback
from lamin-A, as low lamin-A favors the highestcytoplasmic levels of RARG on soft substrates and vice
versa [34]. Lamin-A also influences SRF and YAP1 (a
member of the Hippo signaling pathway) to drive MSC
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stiff matrices is accompanied by the enrichment of YAP1
at the nuclear envelope [34]. Moreover, YAP1 concentrates
at the cytoplasm during MSC adipogenesis, whereas it
translocates into the nucleus during osteogenesis [40].
Crosstalk network determines stem cell fate
A complex and interconnected network of crosstalk be-
tween multiple signals triggered by matrix stiffness af-
fects gene expression and the determination of stem cell
fate (Figure 2B). MSC neurogenic differentiation on soft
substrates is modulated by blocking of the BMP/Smad
signaling pathway. Soft matrix promotes β1 integrin in-
ternalization, which enhances BMPR endocytosis and
further leads to the expression of neuronal genes, in-
cluding microtubule associated protein 2, neurofilament
protein light chain and nestin [17]. Furthermore, inhib-
ition of extracellular signal-regulated kinase (ERK)/mito-
gen-activated protein kinase (MAPK) signaling regulates
keratinocyte differentiation of epidermal stem cells on
soft substrates [41]. It has been shown that reduced clus-
tering of integrins (β1 integrin) and decreased activation
of ERK/MAPK signaling may further stimulate Jun N-
terminal kinase (JNK) to increase AP-1 activity, which
leads to keratinocyte differentiation [41].
The endothelial cell differentiation of cardiac stem
cells is induced by matrix stiffness replicating that of the
myocardium (12 to 16 kPa) in a RhoA-independent
manner, as indicated by increasing expression of platelet
endothelial cell adhesion molecule-1 and vascular endo-
thelial growth factor receptor 2 [42]. Medium stiffness acts
through β1 integrin, causing a reduction of p190RhoGAP,
and subsequently resulting in upregulation and nuclear
translocalization of the endothelial-specific transcription
factors GATA2 and TFII-1 independently of RhoA activa-
tion in cardiac stem cells [42]. Moreover, GATA2 expres-
sion regulated by p190RhoGAP reduces the level of YAP
as part of a nuclear lamin circuit [42]. Myogenic lineage
commitment of MSCs on medium substrates (10.2 kPa) is
regulated by the RhoA-ROCK-dependent cytoskeleton
tension with expression of MYOD, GATA4, α-sarcomeric
actin and myosin heavy chain [12,21]. However, the signal-
ing pathway necessary for myogenesis that is triggered by
the proper cellular tension needs to be clarified in future
work.
MSC osteogenesis on stiff matrices is guided by
the interplay between FAK and RhoA/ROCK signaling,
BMP/Smad and Ras-mediated signaling. MSCs accom-
modate to ECM stiffness via an α2-integrin-ROCK-FAK-
ERK1/2 axis that promotes RUNX2 activity, eventually
leading to osteogenic fate [13]. The BMP/Smad signal
pathway may also influence osteogenesis induced by stiff
substrates, as suppression of the phosphorylation and
nuclear translocation of Smad1/5/8 inhibits osteogenicgene expression of MSCs on BMP-2 mimetic peptide-
grafted substrates with similar stiffness to muscle or
osteoid [24]. Furthermore, matrix stiffness-driven MSC
osteogenesis is also modulated by the Ras pathway asso-
ciated with high phosphorylation levels of Smad1/5/8,
ERK and AKT [43]. The Ras-mediated signaling acts
as a master switch in signaling transduction since it
orchestrates the activity of multiple signaling molecules,
including ERK, phosphatidylinositol-3-kinase/AKT and
Smad, to regulate diverse cellular functions [44]. One of
the well studied pathways that activate Ras and the sub-
sequent cellular response is through ligand binding to a
receptor tyrosine kinase, which is linked to Ras via two
proteins, Grb2 and SOS. Inhibition of Ras by a dominant
negative mutant results in the attenuation of Smad, ERK
and AKT, as well as a reduction in osteogenic marker
expression by MSCs [43]. However, the Ras pathways
are essential but not sufficient for matrix stiffness-
regulated osteogenesis, as constitutively active Ras has
little effect on Smad and AKT phosphorylation or
the osteogenic markers [43]. Therefore, other signaling
networks involved in these processes need to be studied
in the future.
A rapid shift from original mechanosensing to
de novo cell-derived matrix sensing in three-
dimensional cultures
Most current investigations are derived from in vitro
two-dimensional cell culture models that might not truly
reflect the characteristics of the cells in physiological
three-dimensional environments as two-dimensional
cell-matrix interactions are bidirectional, while three-
dimensional ones are omnidirectional. Thus, it might be
more suitable to study the mechanism of matrix stiffness
mechanotransduction in three-dimensional studies. In
fact, inside a three-dimensional microenvironment, the
softness and curvature of biomaterials hinder the forma-
tion of actin stress fibers and cell spreading, and se-
creted factors can be highly concentrated relative to
two-dimensional conditions; thus, it is not surprising
that stem cells may sense ECM stiffness in a different
way [45] (Figure 3). More and more researchers have
shown that the effects of matrix stiffness on stem cell
morphology and differentiation are different in two-
dimensional versus three-dimensional cultures (Table 2).
Myosin-based cytoskeletal tension is unlikely to be
involved in three-dimensional mechanosensing, but in-
tegrin binding still plays an important role according to
studies using pharmacological cytoskeletal inhibitors in
three-dimensional culture (Table 1). In three-dimensional
scaffolds with stiffness ranging from low (0.2 kPa) to
high (59 kPa), MSCs undergoing osteogenic differentiation
lack pronounced actin filaments and microtubules [46], in
contrast to previous reports in two-dimensional culture
Figure 3 Discrepancy between two-dimensional and three-dimensional microenvironments. (A) Cells on a rigid two-dimensional (2D) surface
coated with a continuous layer of matrix develop focal adhesions and stress fibers at the basal surface. Cell-matrix interactions are restricted to
the planar direction and gradients of secreted factors are absent. (B) Inside a three-dimensional (3D) environment, cells display poorly defined
stress fibers due to the softness of biomaterials. Cell adhesions are distributed both in the planar and perpendicular directions with discrete matrix
fibrils, and secreted factors can be highly concentrated.
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ger cell spreading size, along with osteogenesis on stiffer
versus soft substrates [6]. When encapsulated in three-
dimensional scaffolds, MSCs initially express no adhesive
peptides or ECM proteins, but they produce their own
matrix over time, as evidenced by a great increase in fibro-
nectin found around cells. Moreover, blocking of integrin-
ECM interaction by RGDS inhibits MSC osteogenesis in
three-dimensional scaffolds [46]. Thus, integrin binding to
the de novo ECM is essential for stem cell mechanosen-
sing in three-dimensional cultures, in accordance with
previous work [47]. Nevertheless, myosin-based cytoskel-
etal tension and microtubules may not play a part in
matrix stiffness-induced MSC differentiation in three-
dimensional conditions, as disruption of mechanosensing
elements, including actin filament, microtubule formation,
non-muscle myosin II, MLCK and ROCK, does not largely
change their expression of osteogenic markers [46]. Simi-
larly, three-dimensional hydrogels with lower stiffness(approximately 3.5 kPa) promote MSC chondrogenesis,
whereas stiffer hydrogels (approximately 53.6 kPa) lead to
hypertrophic differentiation with more matrix mineralization,
which resembles the terminal differentiation of growth-
plate hypertrophic chondrocytes [48]. The greater
hypertrophic differentiation may not be modulated by a
force-sensing mechanotransduction mechanism be-
cause blocking of ROCK and myosin II has no obvious
effect on major hypertrophic marker expression in stiff
hydrogels [48]. In another study on myoblasts, cells
underwent osteogenesis in medium and stiff substrates,
accompanied by spherical and dot-like actin microfila-
ments with more micron-sized cortical protrusions that
are found to enter the surrounding matrices via β1 in-
tegrin [49]. These results again suggest that integrin
binding is involved in three-dimensional mechanosen-
sing processes.
Importantly, newly self-synthesized cell-derived ECM
probably acts as a key regulator in determining stem cell
Table 2 Effects of matrix stiffness on stem cells in two dimensions versus three dimensions
Stem cell
types
Morphology and cytoskeletal organization Differentiation
Two-dimensional ESCs Col I-coated PDMS: 41 to 260 kPa, lower cell perimeter and less spreading; 2,700 kPa, higher
cell perimeter, increased spreading and more stress fibers [62]
HyA gel: 1.2 kPa, pancreatic beta cell [9].
Col I-coated PDMS: 2,700 kPa, mesendoderm cell and osteoblast [62]
MSCs FN-coated PAAm gel: 1 to 2 kPa, rounded and unspread; ≥5 kPa, well spread and amassed
a large number of stress fibers [63]
Col I gel and Col I-coated gel, 1 kPa, adipocyte and chondrocyte; 15
kPa, smooth muscle cell [64]
Col I gel and Col I-coated PAAm gel: 1 kPa, less spreading and fewer stress fibers; 15 kPa,
more spreading and extensive stress fibers [64]
Col I-coated PAAm gel: 0.1 to 1 kPa, neuron; 8 to 17 kPa, myoblast;
25 to 40 kPa, osteoblast [6]
Col I-coated PAAm gel: 0.1 to 1 kPa, branched and filopodia-rich; 8 to 17 kPa, spindle-
shaped; 25 to 40 kPa, polygonal [6]
Sulfonate-coated PAAm:1 kPa, chondrocyte [25]
Sulfonate-coated PAAm; 1 kPa, round shapes with less stress fibers but more cortical actins;
150 kPa, spread out with strong expression of stress fibers [25]
ASCs Adipose matrix-coated PAAm gel: 2 kPa, compact, rounded and smaller aspect ratio; 20 to
~40 kPa, more spreading and larger aspect ratio [61].
Adipose matrix-coated PAAm gel: 2 kPa, adipocyte [61]
Cardiac
stem cells
FN-coated PAAm gel: 12 to 16 kPa, more rounded and forming organized cellular networks
with rounded gaps; FN-coated glass: fibroblast-like [42]




Col I-coated PAAm gel: 0.1 kPa, cobblestone; 4 kPa, more elongated [60] Col I-coated PAAm gel: 0.1 kPa, luminal epithelial cell; 4 kPa, myoepithelial
cell [60]
Three-dimensional ESCs Col I gel and matrigel: 0.02 to 0.3 kPa, less neurite outgrowth; 0.5 to 1 kPa, branching and
more neurite outgrowth [65]
PLLA, PLGA, PCL coated matrigel: 50 to 100 kPa, ectoderm cell; 100 to
1,000 kPa, endoderm cell; 1,500 to 6,000 kPa, mesoderm cell [7]
Col I gel and matrigel: 0.02 to 0.3 kPa, glial cell; 0.5 to 1 kPa, neuron
[65]
MSCs Col I-HyA gel: 1 kPa, spherical and formed colonies; 10 kPa, flattened [66] PEG-silica thixotropic gel: 7 Pa (τy)a, neuron; 25 Pa (τy) , myoblast; 75 Pa
(τy), osteoblast [54]
PEG gel: 0.2 to 59 kPa, spherical, lack of well-defined actin filaments and microtubules [46] HyA hydrogel: 3.5 kPa, chondrocyte; 53.6 kPa, hypertrophy [48]
Gtn-HPA gel: 0.6 to 2.5 kPa, less spreading, less organized cytoskeletons; 8 to 12 kPa,
greater spreading, more organized cytoskeletons and more stable focal adhesions [67]
Col I-HyA gel: 1 kPa, neuron; 10 kPa, glial cell [66]
PEG gel: 0.2 to 59 kPa, osteoblast [46]
Gtn-HPA gel: 0.6 to 2.5 kPa, neuron; 8 to 12 kPa, myoblast [67]
Alginate gel containing RGD: 5, 10, 22, 45, 110 kPa, grossly spherical and morphology are
not strongly correlated to matrix stiffness [47]
Col I-coated PEG nanofiber: 2 to 5 kPa, endothelial cell; 8 to 15 kPa,
smooth muscle cell [68]
Col I-coated PEG nanofiber: 2 to 5 kPa, less polarized; 8 to 15 kPa, striated, elongated and
greater spreading [68]
PCL nanofiber: 7,100 kPa, chondrocyte; PES-PCL nanofiber: 30,600 kPa,
osteoblast [59]
PCL nanofiber: 7,100 kPa, rounded; PES-PCL nanofiber: 30,600 kPa, spread and higher stress
fiber density [59]
Myoblasts TG-Gtn gel: 2 kPa, elongated and branched, mesh-like or extended actin filaments; 14 to 32
kPa, dot-like actin microfilaments with filopodia [49]
TG-Gtn gel: 14 to 32 kPa, osteoblast [49]
aτy (liquefaction stress): the minimum shear stress required to liquefy the gel is used to measure the substrate stiffness. ASC, adipose-derived stem cell; Col I,
collagen I; ESC, embryonic stem cell; FN, fibronectin; Gtn-HPA, gelatin-hydroxyphenylpropionic acid; HyA, hyaluronic acid; MSC, mesenchymal stem cell; PAAm, polyacrylamide; PCL, poly(ε-caprolactone); PDMS, polydi-
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(32 kPa) substrates comparable to native bone tissue,
as shown by highest calcium deposition and late osteo-
genic marker expression [49]. Interestingly, on medium
substrates most cells express only early osteogenic tran-
scripts, but they also differentiate into osteoblast-like cells
at a later point in time. This phenomenon may occur be-
cause they assemble and deposit their own matrix match-
ing the bone microenvironment [49]. Furthermore, soft
hydrogels contain higher amounts of proteoglycans and
collagen II, both of which are known to facilitate chondro-
genesis but suppress hypertrophic differentiation and
matrix calcification [50]. Additionally, more overall accu-
mulation and uniform spatial distribution of glycosamino-
glycan in soft scaffolds can bind and concentrate some
hypertrophy inhibitory growth factors such as transform-
ing growth factor βs [51]. These may be the reason why
MSCs favor chondrogenic differentiation over hyper-
trophic differentiation in three-dimensional soft environ-
ments [48]. Extremely soft (<0.12 kPa) three-dimensional
hydrogel preferentially induces cell aggregation and osteo-
genic differentiation of MSCs, even without arginine-
glycine-aspartate (RGD) ligands [52]. In soft RGD-alginate
matrices MSCs produce their own fibronectin around cell
aggregates, associated with high expression of the α5 in-
tegrin subunit, and they are likely to effectively reinforce
the hydrogel stiffness by increasing local matrix density
via network contraction and fibronectin assembly [53].
Consequently, depending on cellular rearrangement, a
new mechanical and biochemical microenvironment is
created by local matrix stiffening, cell aggregation and
α5β1 integrin-mediated fibronectin binding. In turn, all of
these changes may control MSC commitment, as stiffer
matrix and cell aggregation have a positive correlation
with osteogenic differentiation [54], and α5 integrin sig-
naling is known to monitor stem cell osteogenesis [55,56].
Altogether, interactions of stem cells entrapped in
a three-dimensional environment with the initial
matrix become less dominant over time, but newly self-
synthesized ECM where cells reside turns into a more
crucial mediator of stem cell fate. Although a mechano-
transduction mechanism dependent on myosin-based
cytoskeletal tension and microtubules seems not to work
in three-dimensional conditions, the early interaction
with the intrinsic stiffness of the original matrix through
integrin binding is clearly decisive. A putative shift from
initial mechanosensing to de novo cell-derived matrix sensing
in three-dimensional conditions may be the mechanism by
which stem cells dynamically perceive their microenvironment
and make fate decisions.
Conclusion and future perspectives
It is becoming increasingly clear that substrate stiffness
plays a central role in determining stem cell fate in two-and three-dimensional cultures (Table 2), while the
mechanisms of mechanotransduction remain unclear.
Based on most results acquired from in vitro two-
dimensional cell culture models, cytoskeleton-based
feedback loops make cells reach maximal mechanosensi-
tivity towards matrix stiffness, and the lamin-A gene cir-
cuit plays a vital role in modulating diverse transcriptional
pathways. Multiple signaling crosstalk triggered by matrix
stiffness finally changes gene expression and determines
stem cell fate. However, cellular mechanosensing is intri-
cate and complex in that substrate stiffness is only one of
multiple mechanical stimuli that stem cells may experi-
ence in vivo. Matrix stiffness may work in concert with
other mechanical cues to regulate and coordinate stem
cell behaviors, such as hydrostatic pressure and fluid shear
stress [26,57]. Nevertheless, as in vivo most cells reside
within a complex environment containing multiple ECM
components, a medley of cell populations and mixtures
of cell-secreted factors, three-dimensional cell culture
models recapitulate the natural tissue environment more
closely. It is highly likely that a very different regulatory
mechanism of stem cell differentiation by substrate stiff-
ness exists in three-dimensional culture. We speculate
stem cells dynamically perceive their microenvironment
through a shift from initial mechanosensing to newly self-
synthesized matrix sensing in a three-dimensional extra-
cellular milieu, but the specific mechanism needs further
research.
Although the value of three-dimensional cell culture
has been proved repeatedly, research to identify stem
cell responses to substrate stiffness in three-dimensional
conditions still faces many challenges. One of the major
challenges is the lack of suitable substrates with physio-
logically relevant properties. For instance, although
thixotropic PEG-silica gels provide an inert environment
for stem cell culture, which avoids the complication of
biological signaling from a biologically derived matrix,
their application as scaffolds are limited due to their in-
sufficient stiffness [54]. On the contrary, silk fibroin has
an inherent tendency to form stiff substrates (>1,000
kPa), which limit its elastomeric biomaterial applications
[58]. Meanwhile, transglutaminase cross-linked gelatin
may be a promising biomaterial due to its mechanical
stiffness (2.5 to 100 kPa), suitable for supporting cell
differentiation during tissue regeneration [49]. Further-
more, nutrients and gas, which also are important
variables that influence stem cell fates in three-
dimensional conditions, diffuse freely through these gels,
regardless of the gel porosity or stiffness. However, al-
though it is possible to modify the substrate stiffness by
varying the degree of hydrogel cross-linking or its com-
position, it is impossible to eliminate the discrepancies
in surface chemistry, topography and porosity. Recently,
electrospinning has been utilized to create mechanically
Lv et al. Stem Cell Research & Therapy  (2015) 6:103 Page 10 of 11distinct scaffolds that have identical surface chemistries
and microstructures, allowing the dissection of the effect
of matrix stiffness on stem cell fate decisions in three di-
mensions [59].
Furthermore, cell density or cell-cell interactions
might also influence the findings in three dimensions.
To minimize the effects of cell density, some researchers
culture cells in scaffolds for a short period until the cell
density reaches approximately 70 to 80% confluence
[59]. During the cellular processes the mechanical prop-
erties such as stiffness, topography and porosity may dy-
namically change and be distributed unevenly across the
gels because of the possible degradation of gels and the
endogenous ECM assembly [47]. Therefore, it is urgent
to further assess the dynamic changes in mechanical
properties of the substrates, and biomaterials with mech-
anical properties that vary across a gradient may create
an ideal platform.
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